Skip to main content
logo
CSPC Pharmaceutical Group Limited (HKG:1093)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
7.09
-0.15 (-2.07%)
Jun 8, 2026, 4:09 PM HKT

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Mainland China Revenue
20.83B25.11B
Mainland China Revenue Growth
-17.05%-7.64%
Other Asian Regions Revenue
1.26B1.18B
Other Asian Regions Revenue Growth
6.95%-25.31%
North America Revenue
890.21M853.04M
North America Revenue Growth
4.36%-3.26%
Europe Revenue
2.43B1.31B
Europe Revenue Growth
84.96%2.85%
Other Geographies Revenue
596.27M553.88M
Other Geographies Revenue Growth
7.65%5.54%

Revenue

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Nervous System Revenue
7.82B9.64B
Nervous System Revenue Growth
-18.95%6.12%
Oncology Revenue
2.20B4.40B
Oncology Revenue Growth
-49.98%-28.33%
Anti-Infectives Revenue
3.32B4.09B
Anti-Infectives Revenue Growth
-18.66%-3.54%
Cardiovascular Revenue
1.83B2.08B
Cardiovascular Revenue Growth
-11.80%-14.79%
Respiratory System Revenue
1.22B1.20B
Respiratory System Revenue Growth
1.98%-23.13%
Digestion and Metabolism Revenue
943.33M1.05B
Digestion and Metabolism Revenue Growth
-10.22%18.18%
Other Therapeutic Areas Revenue
1.45B1.26B
Other Therapeutic Areas Revenue Growth
15.47%0.74%
Total Finished Drugs Revenue
18.80B23.72B
Total Finished Drugs Revenue Growth
-20.76%-7.36%
Vitamin C Revenue
2.23B1.99B
Vitamin C Revenue Growth
11.85%3.36%
Antibiotics Revenue
1.43B1.59B
Antibiotics Revenue Growth
-10.23%-7.18%
Total Bulk Products Revenue
3.66B3.58B
Total Bulk Products Revenue Growth
2.06%-1.60%
Licence Fee Income
1.79B17.83M
Licence Fee Income Growth
9931.41%-48.61%
Functional Food and Others Revenue
1.77B1.69B
Functional Food and Others Revenue Growth
4.46%-22.18%

EBIT

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Finished Drugs Segment Profit
3.87B4.83B
Finished Drugs Segment Profit Growth
-19.82%-27.94%
Vitamin C Segment Profit
191.78M211.28M
Vitamin C Segment Profit Growth
-9.23%4168.26%
Antibiotics Segment Profit
184.43M299.18M
Antibiotics Segment Profit Growth
-38.35%93.83%
Total Bulk Products Segment Profit
376.21M510.45M
Total Bulk Products Segment Profit Growth
-26.30%220.44%
Functional Food and Others Segment Profit
276.06M305.29M
Functional Food and Others Segment Profit Growth
-9.58%-45.63%
Updated Dec 31, 2025. Data Source: Fiscal.ai.